EpCAM expression varies significantly and is differentially associated with prognosis in the luminal B HER2(+), basal-like, and HER2 intrinsic subtypes of breast cancer

S. D. Soysal, Washington University School of Medicine in St. Louis
S. Muenst, Washington University School of Medicine in St. Louis
T. Barbie, Washington University School of Medicine in St. Louis
T. Fleming, Washington University School of Medicine in St. Louis
F. Gao, Washington University School of Medicine in St. Louis
G. Spizzo, Tyrolean Cancer Research Institute
D. Oertil, University Hospital Basel
C. T. Viehl, University Hospital Basel
E. C. Obermann, University Hospital Basel
W. E. Gillanders, Washington University School of Medicine in St. Louis

Abstract